Roche announced a 7% sales increase to 30.9B Swiss francs in H1 2025, with pharmaceuticals leading growth. Core operating profit and earnings per share also rose significantly, rei...
Roche AG reports a 6% sales growth in Q1 2025, with pharmaceuticals leading at 8% increase. CEO Schinecker outlines a USD 50 billion investment plan to strengthen US operations and...
Roche AG kicks off 2025 with a 6% sales increase in Q1, driven by an 8% growth in pharmaceuticals. CEO Schinecker outlines a $50 billion US expansion plan to innovate healthcare so...
Roche AG kicks off fiscal 2025 with a 6% increase in Q1 sales to 15.4 billion Swiss francs, driven by an 8% growth in pharmaceuticals. CEO Schinecker outlines ambitious US expansio...
Roche reports a 6% increase in Q1 sales, totaling 15.4 billion Swiss francs, indicating strong market performance and strategic success in the pharmaceutical industry.
Roche plans a $50 billion investment in the US to expand pharmaceutical manufacturing and create over 12,000 jobs, reinforcing its commitment to innovation and development in the c...
Roche announces a $50 billion investment in the US to expand pharmaceutical operations, creating over 12,000 jobs and strengthening its global presence in healthcare innovation.
